Representative appearance of off-white powder
Off-white powderRepresentative appearance · not batch photography

Pure powder · Singular solution

Palmitoyl Pentapeptide-4 (Pal-KTTKS)

INCI: Palmitoyl Pentapeptide-4

A matrix-repairing pentapeptide for wrinkle prevention and repair, eye contour care and mature skin, with efficacy comparable to retinol without barrier damage.

CAS number
214047-00-4
Catalogue no.
AP105001
Appearance
Off-white powder
Request a quote

Request bulk pricing

Tell us the volume you need for a tailored supply quote.

Buy a sample

Free shipping on sample orders for US-based customers.

Technical data

Specifications

INCI name
Palmitoyl Pentapeptide-4
CAS number
214047-00-4
Sequence
Pal-Lys-Thr-Thr-Lys-Ser-OH
Catalogue no.
AP105001
Other names
Pal-KTTKS
Appearance
Off-white powder
Molecular weight
802.05
Solubility
Oil-soluble
Solution concentration
500 ppm
Recommended use level
1–3%
Available sample sizes
100 mg pure powder sample; 25 mL of 0.05% (500 ppm) solution sample
Pal
Lys
Thr
Thr
Lys
Ser
OH

Verified peptide notation

Molecular identity

Verified chemical notation

An interactive model is shown only when an exact registry structure matches this product. The verified sequence or ingredient identity is shown here without inferring missing coordinates.

CAS number
214047-00-4
Sequence
Pal-Lys-Thr-Thr-Lys-Ser-OH

Physical form

Representative ingredient appearance

Representative appearance of off-white powder
Off-white powderRepresentative appearance · not batch photography

Off-white powder

This stylized image represents the verified catalogue description and product format. It is not a photograph of a specific production batch; request the current COA for batch-specific details.

Performance

Benefits and evidence

  • Repairs the matrix and the epidermis–dermis junction
  • Stimulates expression of wound healing genes
  • Stimulates fibroblasts to reconstruct the extracellular matrix
  • Stimulates synthesis of collagen I and IV and fibre cell proteins

The mechanism for wrinkle reduction involves repairing the matrix and the epidermal-dermal junction, stimulating gene expression for wound healing, and promoting the synthesis of collagen I and IV, fibronectin and glycosaminoglycans.

Use cases

Applications

Downloads

Product documents

The public PDF summarizes the verified product information shown on this page. Use the download button beside the product title above.

Technical data sheetRequest
SDS / MSDSRequest
Batch certificate (COA)Request
Request controlled documents

Need help choosing or formulating this peptide?